BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 23097483)

  • 1. Imaging focal and interstitial fibrosis with cardiovascular magnetic resonance in athletes with left ventricular hypertrophy: implications for sporting participation.
    Waterhouse DF; Ismail TF; Prasad SK; Wilson MG; O'Hanlon R
    Br J Sports Med; 2012 Nov; 46 Suppl 1():i69-77. PubMed ID: 23097483
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The multi-modality cardiac imaging approach to the Athlete's heart: an expert consensus of the European Association of Cardiovascular Imaging.
    Galderisi M; Cardim N; D'Andrea A; Bruder O; Cosyns B; Davin L; Donal E; Edvardsen T; Freitas A; Habib G; Kitsiou A; Plein S; Petersen SE; Popescu BA; Schroeder S; Burgstahler C; Lancellotti P
    Eur Heart J Cardiovasc Imaging; 2015 Apr; 16(4):353. PubMed ID: 25681828
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of hypertrophic cardiomyopathy in highly trained athletes: relevance to pre-participation screening.
    Basavarajaiah S; Wilson M; Whyte G; Shah A; McKenna W; Sharma S
    J Am Coll Cardiol; 2008 Mar; 51(10):1033-9. PubMed ID: 18325444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sudden cardiac death in athletes and the value of cardiovascular magnetic resonance.
    Mavrogeni SI; Bacopoulou F; Apostolaki D; Chrousos GP
    Eur J Clin Invest; 2018 Jul; 48(7):e12955. PubMed ID: 29782639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exercise and heart disease: from athletes and arrhythmias to hypertrophic cardiomyopathy and congenital heart disease.
    Zaidi A; Sharma S
    Future Cardiol; 2013 Jan; 9(1):119-36. PubMed ID: 23259479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of myocardial fibrosis and ventricular dyssynchrony on response to therapy in new-presentation idiopathic dilated cardiomyopathy: insights from cardiovascular magnetic resonance and echocardiography.
    Leong DP; Chakrabarty A; Shipp N; Molaee P; Madsen PL; Joerg L; Sullivan T; Worthley SG; De Pasquale CG; Sanders P; Selvanayagam JB
    Eur Heart J; 2012 Mar; 33(5):640-8. PubMed ID: 22048681
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiac imaging and stress testing asymptomatic athletes to identify those at risk of sudden cardiac death.
    La Gerche A; Baggish AL; Knuuti J; Prior DL; Sharma S; Heidbuchel H; Thompson PD
    JACC Cardiovasc Imaging; 2013 Sep; 6(9):993-1007. PubMed ID: 24029371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of myocardial changes in athletes with native T1 mapping and cardiac functional evaluation using 3 T MRI.
    Görmeli CA; Görmeli G; Yağmur J; Özdemir ZM; Kahraman AS; Çolak C; Özdemir R
    Int J Cardiovasc Imaging; 2016 Jun; 32(6):975-81. PubMed ID: 26920720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Left ventricular hypertrophy in athletes.
    Rawlins J; Bhan A; Sharma S
    Eur J Echocardiogr; 2009 May; 10(3):350-6. PubMed ID: 19246500
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distinguishing hypertrophic cardiomyopathy from athlete's heart physiological remodelling: clinical significance, diagnostic strategies and implications for preparticipation screening.
    Maron BJ
    Br J Sports Med; 2009 Sep; 43(9):649-56. PubMed ID: 19734498
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiovascular magnetic resonance, fibrosis, and prognosis in dilated cardiomyopathy.
    Assomull RG; Prasad SK; Lyne J; Smith G; Burman ED; Khan M; Sheppard MN; Poole-Wilson PA; Pennell DJ
    J Am Coll Cardiol; 2006 Nov; 48(10):1977-85. PubMed ID: 17112987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myocardial fibrosis in athletes-Current perspective.
    Małek ŁA; Bucciarelli-Ducci C
    Clin Cardiol; 2020 Aug; 43(8):882-888. PubMed ID: 32189357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiovascular pre-participation screening of young competitive athletes for prevention of sudden death: proposal for a common European protocol. Consensus Statement of the Study Group of Sport Cardiology of the Working Group of Cardiac Rehabilitation and Exercise Physiology and the Working Group of Myocardial and Pericardial Diseases of the European Society of Cardiology.
    Corrado D; Pelliccia A; Bjørnstad HH; Vanhees L; Biffi A; Borjesson M; Panhuyzen-Goedkoop N; Deligiannis A; Solberg E; Dugmore D; Mellwig KP; Assanelli D; Delise P; van-Buuren F; Anastasakis A; Heidbuchel H; Hoffmann E; Fagard R; Priori SG; Basso C; Arbustini E; Blomstrom-Lundqvist C; McKenna WJ; Thiene G;
    Eur Heart J; 2005 Mar; 26(5):516-24. PubMed ID: 15689345
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sudden cardiac death and the 'athlete's heart'.
    Wight JN; Salem D
    Arch Intern Med; 1995 Jul; 155(14):1473-80. PubMed ID: 7605148
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnosis and management of inherited cardiomyopathies.
    Millar L; Sharma S
    Practitioner; 2014 Oct; 258(1775):21-5, 2-3. PubMed ID: 25591284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Post-mortem evidence of idiopathic left ventricular hypertrophy and idiopathic interstitial myocardial fibrosis: is exercise the cause?
    Whyte G; Sheppard M; George K; Shave R; Wilson M; Prasad S; O'Hanlon R; Sharma S
    Br J Sports Med; 2008 Apr; 42(4):304-5. PubMed ID: 17720799
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence for efficacy of the Italian national pre-participation screening programme for identification of hypertrophic cardiomyopathy in competitive athletes.
    Pelliccia A; Di Paolo FM; Corrado D; Buccolieri C; Quattrini FM; Pisicchio C; Spataro A; Biffi A; Granata M; Maron BJ
    Eur Heart J; 2006 Sep; 27(18):2196-200. PubMed ID: 16831826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Athlete's Heart: Diagnostic Challenges and Future Perspectives.
    De Innocentiis C; Ricci F; Khanji MY; Aung N; Tana C; Verrengia E; Petersen SE; Gallina S
    Sports Med; 2018 Nov; 48(11):2463-2477. PubMed ID: 30251086
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiac magnetic resonance assessment of athletic myocardial fibrosis; Benign bystander or malignant marker?
    Javed W; Malhotra A; Swoboda P
    Int J Cardiol; 2024 Jan; 394():131382. PubMed ID: 37741350
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Athletic Cardiac Adaptation in Males Is a Consequence of Elevated Myocyte Mass.
    McDiarmid AK; Swoboda PP; Erhayiem B; Lancaster RE; Lyall GK; Broadbent DA; Dobson LE; Musa TA; Ripley DP; Garg P; Greenwood JP; Ferguson C; Plein S
    Circ Cardiovasc Imaging; 2016 Apr; 9(4):e003579. PubMed ID: 27033835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.